Furthermore, we explored the correlation between CAPN2 mRNA levels and clinicopathological characteristics using the TCGA-PAAD dataset and revealed that patients with PC with high CAPN2 mRNA levels showed poorer tumor grade, T stage, and tumor status than patients with PC with lower CAPN2 levels (Figure 2). Here, CAPN2 is linked to pachyonychia congenita.